论文部分内容阅读
目的探讨消化性溃疡患者经洛赛克治疗的临床效果。方法从我院2013年3月至2015年9月收治的消化性溃疡患者中随机选取92例进行研究,采用随机数字表法分为对照组(46例,经阿莫西林+克拉霉素治疗)和观察组(46例,经阿莫西林+克拉霉素+洛赛克治疗),对比两组患者的临床治疗效果和不良反应。结果对照组有12例显效,23例有效;观察组有16例显效,28例有效。组间总有效率比较,对照组为76.09%,低于观察组的95.65%,且组间差异显著,有统计学意义(P<0.05)。同时,两组患者均未出现严重的不良反应。结论消化性溃疡患者经洛赛克治疗,在保证安全性的基础上可以有效提升治疗效果,更适宜用于临床治疗。
Objective To investigate the clinical effect of Losec treated patients with peptic ulcer. Methods A total of 92 patients with peptic ulcer admitted to our hospital from March 2013 to September 2015 were randomly divided into control group (46 cases, treated with amoxicillin + clarithromycin) And observation group (n = 46, treated with amoxicillin + clarithromycin + Losec). The clinical effects and adverse reactions of the two groups were compared. Results In the control group, 12 cases were markedly effective and 23 cases were effective. In the observation group, 16 cases were markedly effective and 28 cases were effective. The total effective rate between the two groups was 76.09% in the control group, which was lower than 95.65% in the observation group. There was significant difference between the two groups (P <0.05). At the same time, no serious adverse reactions occurred in both groups. Conclusions Peptic ulcer patients treated with Losec may be effective in improving the therapeutic effect on the basis of ensuring safety and are more suitable for clinical treatment.